SARCOMA, EWING
Clinical trials for SARCOMA, EWING explained in plain language.
Never miss a new study
Get alerted when new SARCOMA, EWING trials appear
Sign up with your email to follow new studies for SARCOMA, EWING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for Tough-to-Treat bone cancer: new combo trial launches
Disease control OngoingThis study tests whether adding the drug abemaciclib to standard chemotherapy can help people with Ewing's sarcoma whose cancer has returned or not responded to treatment. About 46 children and young adults will take part. The goal is to see if the combination slows tumor growth …
Matched conditions: SARCOMA, EWING
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for young sarcoma patients: experimental drug combo targets tough tumors
Disease control TerminatedThis study tests a new drug called PEN-866, which stays in tumor cells longer than normal cells, combined with two standard chemotherapy drugs (vincristine and temozolomide). It is for people aged 12 to 39 with sarcomas (Ewing sarcoma or rhabdomyosarcoma) that have returned or no…
Matched conditions: SARCOMA, EWING
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC